Share This

Related Topics News - EURO

     
 Title only   |   Print 
     
CVC資本啟動 招股 發行價格區間13至15歐元預計本周五掛牌 上市
參與該交易的銀行周一上午表示, 首次公開募股 的 認購 已被投資者多次超額 認 ... IPO 將為CVC提供資金,以在房地產等領域進行更多收購,並可能為去年宣布...
2024-04-23T15:    IPO   IPO   EURO 
Citigroup維持ProQR Therapeutics 評級 為中性 最新 目標價 2.00美元
同花順(300033)美股訊 4月18日Citigroup維持ProQR Therapeutics評級為中性,最新目標價為2.00美元。 ProQR Therapeutics於3月13日發布2023年年報,公司截至2023年12月31日,營業收入952.50萬歐元,同比118.51%,淨利潤-2773.50萬歐元,基本每股收益
2024-04-20T00:    Rating   EURO 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.